Pilot Study of Nilogen 3D-EX and Its Ability to Predict Therapeutic Response to Anti-PD1 or Anti-PDL1 in NSCLC
Clinical trial NCT03371992 · UNKNOWN
Trial details
- NCT number
- NCT03371992
- Sponsor
- Nilogen Oncosystems
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-09
- Primary completion
- 2020-12-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.